Pharma Giants Cut Prices of Weight-Loss Drugs

Americans will soon get a reprieve from the sky-high cost of some weight-loss drugs thanks to a deal President Donald Trump announced recently, Danielle Chemtob reported for Forbes Daily.

Eli Lilly and Novo Nordisk, the makers of Zepbound and Wegovy, will also cut the price Medicare pays for their GLP-1s. (Photo: Zepbound - Eli Lilly) 

The new TrumpRx.gov site launching in January will offer Wegovy and Zepbound injectables for about $350 per month without insurance — far less than the current cost of more than $1,000.

Eli Lilly and Novo Nordisk, the makers of both drugs, will also cut the price Medicare pays for their GLP-1s.

The move is expected to expand access to the medications for Medicare patients, especially since Medicare has not typically been able to cover the drugs when prescribed for weight loss alone.